id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0663-0008,FDA,FDA-2010-E-0663,Letter from U.S. Patent and Trademark Office to Boston Scientific Corporation,Other,Letter(s),2014-04-02T04:00:00Z,2014,4,2014-04-02T04:00:00Z,,2014-04-02T12:58:36Z,,0,0,0900006481695cc1
FDA-2010-E-0663-0007,FDA,FDA-2010-E-0663,U.S. Patent and Trademark Office to Bookof & McAndrews - Letter,Other,Letter(s),2013-11-13T05:00:00Z,2013,11,2013-11-13T05:00:00Z,,2013-11-13T14:48:22Z,,0,0,09000064814795a4
FDA-2010-E-0663-0006,FDA,FDA-2010-E-0663,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:09:35Z,,0,0,090000648119d090
FDA-2010-E-0663-0005,FDA,FDA-2010-E-0663,Determination of Patent Extension Regulatory Review Period: Alair Bronchial Thermoplasty System,Notice,General Notice,2012-05-02T04:00:00Z,2012,5,2012-05-02T04:00:00Z,2012-07-03T03:59:59Z,2012-05-02T20:07:19Z,2012-10516,0,0,090000648100342c
FDA-2010-E-0663-0004,FDA,FDA-2010-E-0663,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2012-04-17T16:42:31Z,,0,0,0900006480ff2485
FDA-2010-E-0663-0003,FDA,FDA-2010-E-0663,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-02-17T05:00:00Z,2011,2,2011-02-17T05:00:00Z,,2011-02-17T16:46:44Z,,0,0,0900006480bf16c0
FDA-2010-E-0663-0002,FDA,FDA-2010-E-0663,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-08-11T04:43:37Z,,0,0,0900006480bc2a9e
FDA-2010-E-0663-0001,FDA,FDA-2010-E-0663,"Danek, et al. - Patent Term Extension Application",Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a9c